Defects in Nicotinamide-adenine Dinucleotide Phosphate Oxidase Genes NOX1 and DUOX2 in Very Early Onset Inflammatory Bowel Disease

Cellular and Molecular Gastroenterology and Hepatology

Volumn 1, Issue 5, 2015, Pages 489-502

  Hayes, Patti ^a   Dhillon, Sandeep ^b,c   O'Neill, Kim ^a   Thoeni, Cornelia ^b,c   Hui, Ken Y ^d   Elkadri, Abdul ^b,c   Guo, Conghui H ^b,c   Kovacic, Lidija ^a   Aviello, Gabriella ^a   Alvarez, Luis A ^e   Griffiths, Anne M ^c   Snapper, Scott B ^f,g   Brant, Steven R ^h   Doroshow, James H ⁱ   Silverberg, Mark S ^j   Peter, Inga ^k   McGovern, Dermot P B ^l   Cho, Judy ^k   Brumell, John H ^b   Uhlig, Holm H ^m   Bourke, Billy ^a,e   Muise, Aleixo M ^b,c   Knaus, Ulla G ^a,e   more..

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d YALE UNIVERSITY   (United States)

^e OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

^j UNIVERSITY OF TORONTO   (Canada)

^k MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^l CEDARS SINAI MEDICAL CENTER   (United States)

^m UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

DUOX2; Inflammatory Bowel Disease; NADPH Oxidase; NOX1; Reactive Oxygen Species; VEOIBD

Indexed keywords

DUAL OXIDASE 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; UNCLASSIFIED DRUG;

ARTICLE; ASHKENAZI JEW; CAMPYLOBACTER ENTERITIS; CHILD; COMPUTER MODEL; CONTROLLED STUDY; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; ENZYME LOCALIZATION; FEMALE; GENE MUTATION; GENE SEQUENCE; HOST RESISTANCE; HUMAN; IN VIVO STUDY; INFLAMMATORY BOWEL DISEASE; INTESTINE CRYPT; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; PANETH CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULCERATIVE COLITIS; VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE;

EID: 84939237581     PISSN: None     EISSN: 2352345X     Source Type: Journal    
DOI: 10.1016/j.jcmgh.2015.06.005     Document Type: Article

References (56)

1. Jostins L., Ripke S., Weersma R.K., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491:119-124.
2. Maloy K.J., Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011, 474:298-306.
3. van den Berg J.M., van Koppen E., Ahlin A., et al. Chronic granulomatous disease: the European experience. PLoS One 2009, 4:e5234.
4. Marks D.J., Miyagi K., Rahman F.Z., et al. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am J Gastroenterol 2009, 104:117-124.
5. Muise A.M., Snapper S.B., Kugathasan S. The age of gene discovery in very early onset inflammatory bowel disease. Gastroenterology 2012, 143:285-288.
6. Somasundaram R., Deuring J.J., van der Woude C.J., et al. Linking risk conferring mutations in NCF4 to functional consequences in Crohn's disease. Gut 2012, 61:1097-1098.
7. Dhillon S.S., Fattouh R., Elkadri A., et al. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. Gastroenterology 2014, 147:680-689.e2.
8. Lambeth J.D., Neish A.S. Nox enzymes and new thinking on reactive oxygen: a double-edged sword revisited. Annu Rev Pathol 2014, 9:119-145.
9. Rada B., Leto T.L. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib Microbiol 2008, 15:164-187.
10. Corcionivoschi N., Alvarez L.A., Sharp T.H., et al. Mucosal reactive oxygen species decrease virulence by disrupting Campylobacter jejuni phosphotyrosine signaling. Cell Host Microbe 2012, 12:47-59.
11. Grasberger H., El-Zaatari M., Dang D.T., et al. Dual oxidases control release of hydrogen peroxide by the gastric epithelium to prevent Helicobacter felis infection and inflammation in mice. Gastroenterology 2013, 145:1045-1054.
12. Patel K.K., Miyoshi H., Beatty W.L., et al. Autophagy proteins control goblet cell function by potentiating reactive oxygen species production. EMBO J 2013, 32:3130-3144.
13. Jones R.M., Luo L., Ardita C.S., et al. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J 2013, 32:3017-3028.
14. Little J.L., Higgins P.T., Ioannidis J.P.A., et al. STREGA: Strengthening the Reporting of Genetic Associations: an extension of the STROBE Statement. Ann Intern Med 2009, 150:206-215. Also available at:. http://www.medicine.uottawa.ca/public-health-genomics/web/eng/strega.html.
15. Moran C.J., Walters T.D., Guo C.H., et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm Bowel Dis 2013, 19:115-123.
16. Muise A.M., Walters T., Xu W., et al. Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis. Gastroenterology 2011, 141:633-641.
17. Adzhubei I.A., Schmidt S., Peshkin L., et al. Amethod and server for predicting damaging missense mutations. Nat Methods 2010, 7:248-249.
18. Kumar P., Henikoff S., Ng P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009, 4:1073-1081.
19. Yuan H.Y., Chiou J.J., Tseng W.H., et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006, 34:W635-W641.
20. Desmet F.O., Hamroun D., Lalande M., et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009, 37:e67.
21. Wang J., Ronaghi M., Chong S.S., et al. pfSNP: An integrated potentially functional SNP resource that facilitates hypotheses generation through knowledge syntheses. Hum Mutat 2011, 32:19-24.
22. Benchimol E.I., Mack D.R., Nguyen G.C., et al. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. Gastroenterology 2014, 147:803-813.e7.
23. Uhlig H.H., Schwerd T., Koletzko S., et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology 2014, 147:990-1007.e3.
24. Levine A., Kugathasan S., Annese V., et al. Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility. Inflamm Bowel Dis 2007, 13:1509-1515.
25. Uhlig H.H. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut 2013, 62:1795-1805.
26. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. JMol Biol 1993, 234:779-815.
27. De Vries S.J., van Dijk M., Bonvin A.M. The HADDOCK web server for data-driven biomolecular docking. Nat Protoc 2010, 5:883-897.
28. Van Dijk A.D., Bonvin A.M. Solvated docking: introducing water into the modelling of biomolecular complexes. Bioinformatics 2006, 22:2340-2347.
29. Luxen S., Noack D., Frausto M., et al. Heterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells. JCell Sci 2009, 122:1238-1247.
30. Yu L., Zhen L., Dinauer M.C. Biosynthesis of the phagocyte NADPH oxidase cytochrome b558. Role of heme incorporation and heterodimer formation in maturation and stability of gp91phox and p22phox subunits. JBiol Chem 1997, 272:27288-27294.
31. Pacquelet S., Lehmann M., Luxen S., et al. Inhibitory action of NoxA1 on dual oxidase activity in airway cells. JBiol Chem 2008, 283:24649-24658.
32. Antony S., Wu Y., Hewitt S.M., et al. Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody. Free Radic Biol Med 2013, 65:497-508.
33. von Lohneysen K., Noack D., Jesaitis A.J., et al. Mutational analysis reveals distinct features of the Nox4-p22 phox complex. JBiol Chem 2008, 283:35273-35282.
34. Martyn K.D., Frederick L.M., von Loehneysen K., et al. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 2006, 18:69-82.
35. Elsinghorst E.A. Measurement of invasion by gentamicin resistance. Methods Enzymol 1994, 236:405-420.
36. Kawahara T., Quinn M.T., Lambeth J.D. Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC Evol Biol 2007, 7:109.
37. Kuhns D.B., Alvord W.G., Heller T., et al. Residual NADPH oxidase and survival in chronic granulomatous disease. NEngl J Med 2010, 363:2600-2610.
38. Debeurme F., Picciocchi A., Dagher M.C., et al. Regulation of NADPH oxidase activity in phagocytes: relationship between FAD/NADPH binding and oxidase complex assembly. JBiol Chem 2010, 285:33197-33208.
39. Gradel K.O., Nielsen H.L., Schonheyder H.C., et al. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 2009, 137:495-501.
40. Moreno J.C., Bikker H., Kempers M.J., et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. NEngl J Med 2002, 347:95-102.
41. Carrichon L., Picciocchi A., Debeurme F., et al. Characterization of superoxide overproduction by the D-Loop(Nox4)-Nox2 cytochrome b(558) in phagocytes-differential sensitivity to calcium and phosphorylation events. Biochim Biophys Acta 2011, 1808:78-90.
42. Von Lohneysen K., Noack D., Wood M.R., et al. Structural insights into Nox4 and Nox2: motifs involved in function and cellular localization. Mol Cell Biol 2010, 30:961-975.
43. Lipinski S., Till A., Sina C., et al. DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses. JCell Sci 2009, 122:3522-3530.
44. Dhillon S.S., Mastropaolo L.A., Murchie R., et al. Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease. Clin Transl Gastroenterol 2014, 5:e46.
45. Latour S., Aguilar C. XIAP deficiency syndrome in humans. Semin Cell Dev Biol 2015, 39:115-123.
46. Speckmann C., Ehl S. XIAP deficiency is a mendelian cause of late-onset IBD. Gut 2014, 63:1031-1032.
47. Haberman Y., Tickle T.L., Dexheimer P.J., et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. JClin Invest 2014, 124:3617-3633.
48. Coant N, Ben Mkaddem S, Pedruzzi E, etal. NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Mol Cell Biol;30:2636-2650.
49. Muzza M., Rabbiosi S., Vigone M., et al. The clinical and molecular characterization of patients with dyshormonogenic congenital hypothyroidism reveals specific diagnostic clues for DUOX2 defects. JClin Endocrinol Metab 2014, 99:E544-E553.
50. Muise A.M., Xu W., Guo C.H., et al. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut 2012, 61:1028-1035.
51. Avitzur Y., Guo C., Mastropaolo L.A., et al. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology 2014, 146:1028-1039.
52. Gevers D., Kugathasan S., Denson L.A., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014, 15:382-392.
53. Bao S., Carr E.D., Xu Y.H., et al. Gp91(phox) contributes to the development of experimental inflammatory bowel disease. Immunol Cell Biol 2011, 89:853-860.
54. Leoni G., Alam A., Neumann P.A., et al. Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. JClin Invest 2013, 123:443-454.
55. Treton X., Pedruzzi E., Guichard C., et al. Combined NADPH oxidase 1 and interleukin 10 deficiency induces chronic endoplasmic reticulum stress and causes ulcerative colitis-like disease in mice. PLoS ONE 2014, 9:e101669.
56. Johnson K.R., Marden C.C., Ward-Bailey P., et al. Congenital hypothyroidism, dwarfism, and hearing impairment caused by a missense mutation in the mouse dual oxidase 2 gene, Duox2. Mol Endocrinol 2007, 21:1593-1602.